Jade Biosciences Income Statement (2020-2026) | JBIO

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
4.33M3.42M5.05M7.25M8.36M10.78M12.22M13.49M16.03M16.88M17.81M20.08M21.25M13.66M31.23M20.02M22.55M22.01M1.50M36.05M
Selling, General & Administrative (Quarter)
1.45M2.78M3.22M3.76M3.85M3.37M3.63M4.15M4.30M4.48M4.25M4.54M4.92M1.38M4.30M3.36M5.23M5.39M6.44M7.39M
Restructuring Costs (Quarter)
0.18M
Other Operating Expenses (Quarter)
-0.08M-0.18M27.04M
Operating Expenses (Quarter)
5.77M6.20M8.27M11.02M12.21M14.15M15.85M17.64M20.34M21.37M22.07M24.62M26.16M14.96M35.54M23.38M27.78M27.40M34.98M43.45M
Operating Income (Quarter)
-5.77M-6.20M-8.27M-11.02M-12.21M-14.15M-15.85M-17.64M-20.34M-21.37M-22.07M-24.62M-26.16M-15.55M-35.54M-23.38M-27.78M-27.40M-34.98M-43.45M
EBIT (Quarter)
-5.77M-6.20M-8.27M-11.02M-12.21M-14.15M-15.85M-17.64M-20.34M-21.37M-22.07M-24.62M-26.16M-15.55M-35.54M-23.38M-27.78M-27.40M-34.98M-43.45M
Non-operating items
Non Operating Investment Income (Quarter)
0.04M
Other Non Operating Income (Quarter)
-0.00M0.02M0.01M0.11M-0.01M0.00M1.75M1.12M1.31M0.00M-0.00M1.39M-0.03M0.09M-0.01M
Non Operating Income (Quarter)
0.00M0.02M0.05M0.11M0.23M0.56M0.93M1.12M1.31M1.80M1.71M1.43M1.40M0.39M-11.44M-14.79M-4.36M2.23M3.10M3.09M
Net income details
EBT (Quarter)
-53.21M-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.35M
Tax Provisions (Quarter)
0.10M
Profit After Tax (Quarter)
-5.78M-6.18M-8.22M-11.49M-11.99M-13.59M-14.72M-16.52M-19.02M-19.59M-19.95M-23.46M-24.77M-16.28M-46.98M-38.17M-32.13M-25.12M-31.80M-40.37M
Income from Continuing Operations (Quarter)
-53.21M-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M
Consolidated Net Income (Quarter)
-53.21M-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M
Income towards Parent Company (Quarter)
-53.21M-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M
Net Income towards Common Stockholders (Quarter)
-53.21M-6.18M-8.22M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M
Additional items
EPS (Basic) (Quarter)
-0.01M-9.06-23.41-15.64-62.87-69.13-22.57-85.11-69.89-49.53-29.49-148.69-32.71-18.88-57.53-46.09-2.46-1.43-1.12-0.70
EPS (Diluted) (Quarter)
-9.06-23.41-15.64-62.87-69.13-22.57-85.11-69.89-49.53-29.49-148.69-32.71-18.88-57.53-46.09-2.46-1.43-1.12-0.70
Shares Outstanding (Quarter)
0.01M0.68M0.35M0.70M0.70M0.70M0.70M0.71M0.72M0.79M0.75M0.79M0.82M0.82M0.82M0.83M28.43M39.58M31.36M57.78M
Shares Outstanding (Diluted) (Quarter)
0.68M0.35M0.70M0.70M0.70M0.70M0.71M0.72M0.79M0.75M0.79M0.82M0.82M0.82M0.83M28.43M39.58M31.36M57.78M
Shares Outstanding (Entity) (Quarter)
0.70M0.35M0.70M0.70M0.70M0.71M0.71M0.79M0.79M0.79M0.80M0.82M0.82M0.83M0.83M
EBITDA (Quarter)
-5.77M-6.20M-8.27M-11.02M-12.21M-14.15M-15.85M-17.64M-20.34M-21.37M-22.07M-24.62M-26.16M-15.55M-35.54M-23.38M-27.78M-27.40M-34.98M-43.45M
Interest Expenses (Quarter)
47.44M42.44M-0.00M41.11M31.63M34.15M-0.07M42.61M29.92M17.75M0.12M93.46M0.71M0.01M2.80M42.22M29.30M1.06M
Tax Rate (Quarter)
-0.25%